InMed Pharmaceuticals Inc. (INM) NASDAQ
0.63
-0.021(-3.21%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.63
-0.021(-3.21%)
Currency In USD
| Market Cap | 3.17M |
| Enterprise Value | -10.91M |
| P/E Ratio | -0.01 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0 |
| Enterprise/Revenue | -7.72 |
| Enterprise/EBITDA | 546.45 |
| Fiscal Year | June 30, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.27 |
| Operating Margin | -0.01 |
| Return On Assets | -0.02 |
| Return On Equity | -0.1 |
| Revenue | 4.94M |
| Revenue/Share | 163.99 |
| Gross Profit | 1.71M |
| EBITDA | -7.26M |
| Net Income | -8.16M |
| Diluted EPS | -8.36 |
| Total Cash | 5.2M |
| Total Cash/Share | 1,284.66 |
| Total Debt | 420,147 |
| Total Debt/Equity | 0 |
| Current Ratio | 3.11 |
| Book Value Per Share | 1,702.43 |
| 52-Week Change | -81.13 |
| 52-Week High | 7.98 |
| 52-Week Low | 0.57 |
| Moving Average 50 Days | 0.74 |
| Moving Average 200 Days | 1.43 |
| Average Volume | 98,790 |
| Shares Outstanding | 1.81M |
| % Held by Institutions | 0 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | November 14, 2024 |